US appeals court ruling gives Teva boost over Cozaar/Hyzaar exclusivity
04 March 2010
Nancy Faigen
Please Login to read the full article.
04 March 2010
Nancy Faigen
A federal appeals court has ruled in favour of
Teva Pharmaceutical Industries and overturned a lower court decision which held that the firm had forfeited 180 days of marketing exclusivity for its generic versions of
Merck and Co's antihypertensives Cozaar (losartan potassium) and Hyzaar...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Supreme Court rules against statistically significant 'bright-line' rule in Matrixx
- US Capitol Capsule: 11th Circuit's severability ruling could save data exclusivity from another fight
- Supreme Court ranks inventors ahead of contractors in Bayh-Dole case
- US appeals judges ponder if health reform forces inactive bystanders into stream of commerce
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
